发明名称 |
SPARC-DERIVED CANCER REJECTION ANTIGEN PEPTIDE AND PHARMACEUTICAL COMPRISING THE SAME |
摘要 |
<p>The object is to identify a peptide derived from SPARC protein which can induce a human cytotoxic (killer) T cell and a helper T cell both reactive to a tumor, and to provide a means for enabling a tumor immunotherapy in a cancer patient having a high level of SPARC expression. Disclosed is a peptide (A) or (B): (A) a peptide which comprises an amino acid sequence depicted in any one of SEQ ID NOs:1-3; and (B) a peptide which comprises an amino acid sequence having the substitution or addition of one or several amino acid residues in a peptide comprising an amino acid sequence depicted in any one of SEQ ID NOs:1-3 and which can induce a killer T cell.</p> |
申请公布号 |
KR20090038873(A) |
申请公布日期 |
2009.04.21 |
申请号 |
KR20097000778 |
申请日期 |
2007.06.15 |
申请人 |
KUMAMOTO UNIVERSITY;ONCOTHERAPY SCIENCE, INC. |
发明人 |
NISHIMURA. YASUHARU;IKUTA YOSHIAKI;NAKATSURU SHUICHI |
分类号 |
C07K14/47;A61K38/00;A61P35/00;C07K16/30 |
主分类号 |
C07K14/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|